Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 3/20 | 0.49 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.49 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.49 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.49 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.47 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | NCF1 | P14598 | 1/20 | 0.42 |
| ▸ | METAP1 | P53582 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18284881 | 0.77 | ADRA2C (0.58) | ADRA2CHRH4HRH3NCF1 | |
| SCHEMBL27174408 | 0.75 | CHKA (0.47) | PIK3CDPIK3CAPIK3CGMETAP1 | |
| SCHEMBL27174416 | 0.75 | AKT1 (0.42) | ADRA2CMETAP1 | |
| SCHEMBL24782983 | 0.72 | ADRA2C (0.50) | ADRA2CHRH4METAP1 | |
| SCHEMBL30463625 | 0.71 | DHFR (0.56) | ADRA2CHRH4HRH3NCF1DHFR | |
| SCHEMBL12156788 | 0.70 | DRD2 (0.54) | ADRA2CHRH4METAP1 | |
| SCHEMBL27306265 | 0.70 | GRM1 (0.47) | ADRA2CHRH4 | |
| SCHEMBL28012222 | 0.70 | HRH4 (0.51) | ADRA2CHRH4HRH3DHFR | |
| SCHEMBL6678524 | 0.69 | METAP1 (0.60) | ADRA2CMETAP1 | |
| SCHEMBL16892046 | 0.69 | HRH4 (0.58) | ADRA2CHRH4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113135898-B | Anticancer quinoxaline pyrimidine amine heterocyclic compound and preparation method and application thereof | 中国药科大学 | 2022-02-11 | — | — | CN | disclosed |